- 1、本文档共27页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
* Overall, survival at one and two years was 89.3% and 81.6%, respectively, in the ICD treated patients, and 82.3% and 74.7% in AAD treated patients. For patients with an LVEF 0.20, the survival rate was 82.4% and 71.6% at one and two years in the ICD treated patients, respectively, and 73.0% and 63.8% in the AAD treated patients. In patients with an LVEF between 0.20 and 0.34, the overall survival rate was 82.9% and 82.5% at one and two years, respectively, in the ICD treated patients and 79.8% and 71.8% in the AAD treated patients. In patients with an LVEF 0.34, there was no difference in survival between AAD treated patients and ICD treated patients. For patients with an LVEF between 0.20 and 0.34, there was statistically improved survival with an ICD as compared with AAD therapy (p0.05). In the smaller subgroup with an LVEF 0.20, the same magnitude of survival difference was seen as in the 0.20 to 0.34 LVEF group, but that difference did not reach statistical significance. 3Domanski MJ, Saksena S, Epstein AE, et al. Relative Effectiveness of the Implantable Cardioverter-Defibrillator and Antiarrhythmic Drugs in Patients With Varying Degrees of Left Ventricular Dysfunction Who Have Survived Malignant Ventricular Tachyarrhythmias. J Am Coll Cardiol. 1999;34:1090-1095. * The MADIT-II study showed a 31% statistically significant reduction in overall mortality with ICD therapy compared to conventional therapy at the end of study follow-up. The absolute mortality benefit was 5.6%. 所有具统计学意义的ICD临床试验中绝对好处最小的临床试验,可能与较高的B受体阻滞剂的使用(70%)和较低的胺碘酮的使用(13%在ICD组对10%在对照组)有关 * Besides the increase in CHF hospitalization, there were no other unexpected adverse outcomes with ICD therapy. * In the MADIT II study, the mortality rate of patients receiving therapy for VF was over 50%at 2 years. Eleven percent of patients in the SCD-HeFT trial who received a single shock died within 24H, and the average life expectancy thereafter was 1 year.(Heart Rhythm 2006;3:S40.) * 一级和二级预防临床试验均显示
您可能关注的文档
- 2006年高考文科数学试题湖北卷.doc
- 2007年度全国注册土木工程师水利水电工程执业资格考试专业知识试卷下午.doc
- 2007年江苏造价员考试试题基础部分.doc
- 2007年高考病句第一轮复习课件系列3.ppt
- 2009~2014年自考05624心理治疗一试题答案历年试题及答案汇总.doc
- 2012中毒2医学必看试题带详细解析答案.doc
- 2012年导游资格考试旅游政策法规模拟试卷4中大网校.doc
- 2010年江苏省徐州市中考数学试卷及答案word版.doc
- 2014中国烹饪中式烹调师劳保版授课教案:烹调方法05.doc
- 2014中国烹饪中式烹调师劳保版授课教案:烹调方法03.doc
- 铁路隧道底鼓风险动态评估与综合整治技术的深度剖析与实践应用.docx
- 吸收犯存在范围的多维审视与界定.docx
- 大学生陌生人信任度:现状剖析与影响因素的深度探究.docx
- 全球金融危机下上海经济学门类毕业生就业的冲击与调适:基于多维度的剖析与展望.docx
- 小型软件团队敏捷风险管理:策略、实践与优化路径.docx
- 锦红片在ERCP术后高淀粉酶血症及胰腺炎预防中的临床价值探究.docx
- 法治视角下我国湿地保护的困境与突破.docx
- 从法律基石到多元实践:非物质文化遗产进校园的深度剖析与展望.docx
- 行政决策责任追究制度的法治化进路.docx
- 基于ORACLE的校园一卡通消费系统设计方案.docx
文档评论(0)